Brain Advance Access originally published online on October 9, 2006
Brain 2006 129(11):3103-3114; doi:10.1093/brain/awl268
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frontotemporal dementia and parkinsonism associated with the IVS1+1G
A mutation in progranulin: a clinicopathologic study
1 Departments of Neurology, Mayo Clinic Rochester, MN 2 Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN 3 Diagnostic RadiologyNeuroradiology, Mayo Clinic Rochester, MN 4 Psychiatry and Psychology, Mayo Clinic Rochester, MN 5 Neuropathology Laboratory, Mayo Clinic Jacksonville, FL, USA 6 Neurogenetics Laboratory, Mayo Clinic Jacksonville, FL, USA 7 Department of Medicine, University of Toronto Toronto, Ontario, Canada 8 Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation USA
Correspondence to: Bradley F. Boeve, MD, Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA E-mail: bboeve{at}mayo.edu
We previously reported a kindred with three cases of dementia, in which the proband exhibited features typical of frontotemporal dementia and parkinsonism (FTDP). An arginine insertion at codon 352 (insR352) in the presenilin-1 (PSEN1) gene was identified in the proband, but analyses in plasma and CSF suggested a mechanism of neurodegeneration not directly related to amyloid pathophysiology. The proband was followed with yearly evaluations of functional, clinical, neuropsychologic, neuropsychiatric and radiologic status, which showed relatively linear change over the initial 4 years of assessment. Upon the proband's death at age 63, neuropathologic examination revealed frontotemporal lobar degeneration (FTLD) with ubiquitin-positive inclusions (FTLD-U). We recently identified several kindreds with familial FTDP associated with mutations in the progranulin (PGRN) gene, particularly in those cases with neuronal intranuclear inclusions. Our proband was indeed found to have such inclusions, and PGRN analysis in this proband revealed the G to A mutation in the exon 1 splice donor site (IVS1+1G
A) which is predicted to destroy the 5'-splice site of exon 1 and remove the start methionine codon and hence completely block any PGRN protein from being generated. These findings suggest that the insR352 PSEN1 is not pathogenic, and the IVS1+1G
A mutation in PGRN causes FTDP associated with FTLD-U pathology and represents a new class of neurodegenerative diseasethe hypoprogranulinopathies.
Key Words: frontotemporal dementia; progranulin; presenilin; neurodegenerative disease; neurogenetics
Abbreviations: Aß, beta-amyloid; FTD, frontotemporal dementia; NFT, neurofibrillary tangles; SP, senile plaques; VV, ventricular volume; WBV, whole-brain volume
Received July 31, 2005. Revised August 29, 2006. Accepted August 30, 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C.-E. Yu, T. D. Bird, L. M. Bekris, T. J. Montine, J. B. Leverenz, E. Steinbart, N. M. Galloway, H. Feldman, R. Woltjer, C. A. Miller, et al. The Spectrum of Mutations in Progranulin: A Collaborative Study Screening 545 Cases of Neurodegeneration Arch Neurol, February 1, 2010; 67(2): 161 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Kelley, W. Haidar, B. F. Boeve, M. Baker, M. Shiung, D. S. Knopman, R. Rademakers, M. Hutton, J. Adamson, K. M. Kuntz, et al. Alzheimer Disease-like Phenotype Associated With the c.154delA Mutation in Progranulin Arch Neurol, February 1, 2010; 67(2): 171 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van der Zee, K. Sleegers, and C. V. Broeckhoven Invited Article: The Alzheimer disease-frontotemporal lobar degeneration spectrum Neurology, October 7, 2008; 71(15): 1191 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Revuelta, A. Rosso, and C. F. Lippa Association Between Progranulin and {beta}-Amyloid in Dementia With Lewy Bodies American Journal of Alzheimer's Disease and Other Dementias, October 1, 2008; 23(5): 488 - 493. [Abstract] [PDF] |
||||
![]() |
B. F. Boeve and M. Hutton Refining Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17: Introducing FTDP-17 (MAPT) and FTDP-17 (PGRN) Arch Neurol, April 1, 2008; 65(4): 460 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Rohrer, J. D. Warren, R. Omar, S. Mead, J. Beck, T. Revesz, J. Holton, J. M. Stevens, S. Al-Sarraj, S. M. Pickering-Brown, et al. Parietal Lobe Deficits in Frontotemporal Lobar Degeneration Caused by a Mutation in the Progranulin Gene Arch Neurol, April 1, 2008; 65(4): 506 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Pickering-Brown, S. Rollinson, D. Du Plessis, K. E. Morrison, A. Varma, A. M. T. Richardson, D. Neary, J. S. Snowden, and D. M. A. Mann Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations Brain, March 1, 2008; 131(3): 721 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Le Ber, A. Camuzat, D. Hannequin, F. Pasquier, E. Guedj, A. Rovelet-Lecrux, V. Hahn-Barma, J. van der Zee, F. Clot, S. Bakchine, et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study Brain, March 1, 2008; 131(3): 732 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shankaran, A. Capell, A. T. Hruscha, K. Fellerer, M. Neumann, B. Schmid, and C. Haass Missense Mutations in the Progranulin Gene Linked to Frontotemporal Lobar Degeneration with Ubiquitin-immunoreactive Inclusions Reduce Progranulin Production and Secretion J. Biol. Chem., January 18, 2008; 283(3): 1744 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Goldman, J. Adamson, A. Karydas, B. L. Miller, and M. Hutton New Genes, New Dilemmas: FTLD Genetics and Its Implications for Families American Journal of Alzheimer's Disease and Other Dementias, January 1, 2008; 22(6): 507 - 515. [Abstract] [PDF] |
||||
![]() |
J.C. Schymick, K. Talbot, and B.J. Traynor Genetics of sporadic amyotrophic lateral sclerosis Hum. Mol. Genet., October 15, 2007; 16(R2): R233 - R242. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hardy and A. Singleton REPORTING AND INTERPRETATION OF GENETIC VARIANTS IN CASES AND CONTROLS Neurology, July 3, 2007; 69(1): 111 - 112. [Full Text] [PDF] |
||||
![]() |
Y A L Pijnenburg, S N M Schoonenboom, P D Mehta, S P Mehta, C Mulder, R Veerhuis, M A Blankenstein, and P Scheltens Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 735 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasegawa, T. Arai, H. Akiyama, T. Nonaka, H. Mori, T. Hashimoto, M. Yamazaki, and K. Oyanagi TDP-43 is deposited in the Guam parkinsonism-dementia complex brains Brain, May 1, 2007; 130(5): 1386 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Leverenz, C. E. Yu, T. J. Montine, E. Steinbart, L. M. Bekris, C. Zabetian, L. K. Kwong, V. M-Y. Lee, G. D. Schellenberg, and T. D. Bird A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology Brain, May 1, 2007; 130(5): 1360 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Goedert and M. G. Spillantini Frontotemporal lobar degeneration through loss of progranulin function. Brain, November 1, 2006; 129(Pt 11): 2808 - 2810. [Full Text] [PDF] |
||||
![]() |
S. M. Pickering-Brown, M. Baker, J. Gass, B. F. Boeve, C. T. Loy, W. S. Brooks, I. R. A. Mackenzie, R. N. Martins, J. B. J. Kwok, G. M. Halliday, et al. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain, November 1, 2006; 129(Pt 11): 3124 - 3126. [Abstract] [Full Text] [PDF] |
||||






